Interdisciplinary Graduate Program in Bioscience, Faculty of Science, Kasetsart University, Bangkok, 10900, Thailand.
Center for Advanced Studies in Nanotechnology for Chemical, Food and Agricultural Industries, KU Institute for Advanced Studies, Kasetsart University, Bangkok, 10900, Thailand.
J Comput Aided Mol Des. 2019 Aug;33(8):745-757. doi: 10.1007/s10822-019-00221-z. Epub 2019 Sep 7.
Protein kinases are an important class of enzymes that play an essential role in virtually all major disease areas. In addition, they account for approximately 50% of the current targets pursued in drug discovery research. In this work, we explore the generation of structure-based quantum mechanical (QM) quantitative structure-activity relationship models (QSAR) as a means to facilitate structure-guided optimization of protein kinase inhibitors. We explore whether more accurate, interpretable QSAR models can be generated for a series of 76 N-phenylquinazolin-4-amine inhibitors of epidermal growth factor receptor (EGFR) kinase by comparing and contrasting them to other standard QSAR methodologies. The QM-based method involved molecular docking of inhibitors followed by their QM optimization within a ~ 300 atom cluster model of the EGFR active site at the M062X/6-31G(d,p) level. Pairwise computations of the interaction energies with each active site residue were performed. QSAR models were generated by splitting the datasets 75:25 into a training and test set followed by modelling using partial least squares (PLS). Additional QSAR models were generated using alignment dependent CoMFA and CoMSIA methods as well as alignment independent physicochemical, e-state indices and fingerprint descriptors. The structure-based QM-QSAR model displayed good performance on the training and test sets (r ~ 0.7) and was demonstrably more predictive than the QSAR models built using other methods. The descriptor coefficients from the QM-QSAR models allowed for a detailed rationalization of the active site SAR, which has implications for subsequent design iterations.
蛋白激酶是一类重要的酶,几乎在所有主要疾病领域都发挥着重要作用。此外,它们约占药物发现研究中当前目标的 50%。在这项工作中,我们探索了基于结构的量子力学(QM)定量构效关系模型(QSAR)的生成,作为一种促进蛋白激酶抑制剂结构导向优化的方法。我们通过比较和对比其他标准 QSAR 方法,探讨了是否可以为一系列 76 种 N-苯基喹唑啉-4-胺表皮生长因子受体(EGFR)激酶抑制剂生成更准确、可解释的 QSAR 模型。基于 QM 的方法涉及抑制剂的分子对接,然后在 EGFR 活性位点的300 个原子簇模型中对其进行 QM 优化,在 M062X/6-31G(d,p) 水平下。对每个活性位点残基的相互作用能进行了成对计算。通过将数据集以 75:25 的比例分割为训练集和测试集,然后使用偏最小二乘法(PLS)进行建模,生成了 QSAR 模型。还使用基于对齐的 CoMFA 和 CoMSIA 方法以及基于对齐的物理化学、e-状态指数和指纹描述符生成了其他 QSAR 模型。基于结构的 QM-QSAR 模型在训练集和测试集上表现出良好的性能(r0.7),并且明显比使用其他方法构建的 QSAR 模型更具预测性。来自 QM-QSAR 模型的描述符系数允许对活性位点 SAR 进行详细的合理化,这对随后的设计迭代具有重要意义。